Literature DB >> 2478855

Antinociceptive effect of spinal cholinergic stimulation: interaction with substance P.

M D Smith1, X H Yang, J Y Nha, J J Buccafusco.   

Abstract

Activation of central muscarinic receptors results in an antinociceptive response in experimental animals. Employing intrathecal (i.t.) injection and radiant heat applied to a rat's tail as the experimental paradigm, a spinally-mediated antinociceptive response was obtained following injection of cholinergic agonists. Since "cholinergic' analgesia is mediated independently of the opiate system, the possibility was considered that this response was mediated through inhibition of the local release of substance P. Rats were prepared with indwelling i.t. catheters which terminated in the L2-L3 region of the spinal cord. I.t. injection of carbachol (0.05-5 micrograms) or neostigmine (1-10 micrograms), but not nicotine (0.5-10 micrograms) produced dose-related increases in tail flick latencies. Pretreatment with i.t. injection of atropine or hemicholinium-3 significantly inhibited the antinociceptive response to neostigmine. Spinal substance P levels were measured 30 min following 0.5 micrograms carbachol. Levels in the dorsal horn were reduced by 30% compared with saline controls. Levels in the ventral horn were unchanged by carbachol. These results support the role of endogenous spinal acetylcholine in pain modification and suggest an interaction with substance P neurons of the dorsal spinal cord.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2478855     DOI: 10.1016/0024-3205(89)90127-6

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  10 in total

1.  Diabetic neuropathy enhances voltage-activated Ca2+ channel activity and its control by M4 muscarinic receptors in primary sensory neurons.

Authors:  Xue-Hong Cao; Hee Sun Byun; Shao-Rui Chen; Hui-Lin Pan
Journal:  J Neurochem       Date:  2011-09-21       Impact factor: 5.372

2.  Muscarinic facilitation of GABA release in substantia gelatinosa of the rat spinal dorsal horn.

Authors:  H Baba; T Kohno; M Okamoto; P A Goldstein; K Shimoji; M Yoshimura
Journal:  J Physiol       Date:  1998-04-01       Impact factor: 5.182

3.  Loss of muscarinic antinociception by antisense inhibition of M(1) receptors.

Authors:  C Ghelardini; N Galeotti; A Bartolini
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

4.  Alleviation of chronic pain following rat spinal cord compression injury with multimodal actions of huperzine A.

Authors:  Dou Yu; Devang K Thakor; Inbo Han; Alexander E Ropper; Hariprakash Haragopal; Richard L Sidman; Ross Zafonte; Steven C Schachter; Yang D Teng
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-05       Impact factor: 11.205

5.  The effects of cholinoceptor agonists and antagonists on C-fibre evoked responses in the substantia gelatinosa of neonatal rat spinal cord slices.

Authors:  L Bleazard; R Morris
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

6.  Muscarinic excitatory and inhibitory mechanisms involved in afferent fibre-evoked depolarization of motoneurones in the neonatal rat spinal cord.

Authors:  T Kurihara; H Suzuki; M Yanagisawa; K Yoshioka
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

7.  Is botulinum toxin useful in treating headache? No.

Authors:  Mark Obermann; Hans-Christoph Diener
Journal:  Curr Treat Options Neurol       Date:  2009-01       Impact factor: 3.598

8.  Depression by nicotine of pain-related nociceptive activity in the rat thalamus and spinal cord.

Authors:  I Jurna; P Krauss; J Baldauf
Journal:  Clin Investig       Date:  1993-12

9.  Spinal muscarinic receptors are activated during low or high frequency TENS-induced antihyperalgesia in rats.

Authors:  R Radhakrishnan; K A Sluka
Journal:  Neuropharmacology       Date:  2003-12       Impact factor: 5.250

Review 10.  The evolution of spinal/epidural neostigmine in clinical application: Thoughts after two decades.

Authors:  Gabriela Rocha Lauretti
Journal:  Saudi J Anaesth       Date:  2015-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.